Curated Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
+4,776
New +$259K 0.02% 232
2024
Q1
– Sell
-5,737
Closed -$369K – 165
2023
Q4
$332K Buy
5,737
+715
+14% +$38.2K 0.05% 106
2023
Q3
$265K Buy
+5,022
New +$263K 0.05% 113
2023
Q2
– Sell
-4,603
Closed -$230K – 138
2023
Q1
$230K Sell
4,603
-915
-17% -$43.1K 0.05% 113
2022
Q4
$255K Sell
5,518
-397
-7% -$17.2K 0.06% 109
2022
Q3
$228K Hold
5,915
– – 0.07% 109
2022
Q2
$220K Buy
+5,915
New +$241K 0.06% 116

Other funds holding BSX

Curated Wealth Partners's BSX Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in Boston Scientific (BSX) in Q2 2026: 4,776 shares worth $204K. The stake represents 0.02% of the portfolio and ranks #232 among its holdings. This is a return to the name: Curated Wealth Partners previously reported a position in BSX as recently as Q4 2023.

Curated Wealth Partners first reported a position in BSX in Q2 2022 and has held it in 7 quarters since. The position peaked at $332K in Q4 2023. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Curated Wealth Partners held 4,776 shares of Boston Scientific worth $204K as of Q2 2026.
  • Boston Scientific was a new Curated Wealth Partners position in Q2 2026.
  • Boston Scientific made up 0.02% of Curated Wealth Partners's portfolio in Q2 2026, its #232 holding.
  • Curated Wealth Partners first reported a position in Boston Scientific in Q2 2022 and has held it in 7 quarters since.
  • Curated Wealth Partners's Boston Scientific position peaked at $332K in Q4 2023.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.